4
Changes in Ownership
Solid Biosciences Inc. Filed Acc 0001193125-25-308118
Chief Operating Officer sold 4,932 shares at $5.11 ($25,203)
- Chief Operating Officer acquired 13,051 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Howton David T Chief Operating Officer | 2025-12-02 | Option exercise 10b5-1 | +13,051 | 37,840 | D | ||
| Howton David T Chief Operating Officer | 2025-12-03 | Sale 10b5-1 | −4,932 | $5.11 | $25,203 | 32,908 | D |
| Derivatives | |||||||
| Howton David T Chief Operating Officer | 2025-12-02 | Option exercise · Restricted Stock Units 10b5-1 | −13,051 | 13,052 | D | ||
| Open-market sales · 4,932 sh · avg $5.11 · $25,203 | |||||||
Loading xslF345X05/ownership.xml…